Tim Heymann
Technical University Darmstadt Peter Grünberg Straße 4 64287 Darmstadt Germany
Darmstadt, HE 64287, Germany
Darmstadt, HE 64287, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: Discovery of fully synthetic FKBP12-mTOR molecular glues.
Journal: Chemical science
Published: March 02, 2026
Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 30, 2025
Discovery of fully synthetic FKBP12-mTOR molecular glues.
Journal: Chemical science
Published: October 11, 2024
SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators.
Journal: Journal of neuroinflammation
Published: April 25, 2023
Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51.
Journal: ACS pharmacology & translational science
Published: November 21, 2022
Detection and Verification of a Key Intermediate in an Enantioselective Peptide Catalyzed Acylation Reaction.
Journal: Molecules (Basel, Switzerland)
Published: August 18, 2022
SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain.
Journal: Journal of neuroinflammation
Published: August 11, 2022
Fenton-Chemistry-Based Oxidative Modification of Proteins Reflects Their Conformation.
Journal: International journal of molecular sciences
Published: August 08, 2021
Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 05, 2021
Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.
Journal: Angewandte Chemie (International ed. in English)
Published: December 31, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026